Astra vaccine guidance will have negligible impact on rollout -England's deputy chief medic
Astra vaccine guidance will have negligible impact on rollout -England's deputy chief medic
"Because of our supply situation in relation to alternative vaccines, the effect on the timing of our overall programme should be zero or negligible," he said at a briefing on Wednesday.
(Reporting by Guy Faulconbridge and Kate Holton, Writing by
Paul Sandle; editing by James Davey)
((paul.sandle@thomsonreuters.com; +44 20 7542 6843; Reuters
Messaging: paul.sandle.thomsonreuters.com@reuters.net)
LONDON, April 7 (Reuters) - Britain's recommendation against giving the Oxford-AstraZeneca COVID-19 vaccine to those aged under 30 due to the risk of blood clots will have a negligible impact on the vaccine programme, England's deputy chief medical officer Jonathan Van-Tam said.
"Because of our supply situation in relation to alternative vaccines, the effect on the timing of our overall programme should be zero or negligible," he said at a briefing on Wednesday.
(Reporting by Guy Faulconbridge and Kate Holton, Writing by
Paul Sandle; editing by James Davey)
((paul.sandle@thomsonreuters.com; +44 20 7542 6843; Reuters
Messaging: paul.sandle.thomsonreuters.com@reuters.net)
倫敦,4月7日(路透社)-英國副首席醫療官喬納森·範-塔姆説,英國建議30歲以下的人不給30歲以下的人接種牛津-阿斯利康新冠肺炎疫苗,因為有血栓的風險,這對疫苗計劃的影響可以忽略不計。他在週三的一次吹風會上表示:“由於我們在替代疫苗方面的供應狀況,對我們整個計劃的時間安排的影響應該是零或可以忽略不計。”(Guy Faulconbridge和Kate Holton報道,編劇:保羅·桑德爾(Paul Sandle;詹姆斯·戴維編輯)(paul.sandle@thomsonreurs.com;+44 20 7542 6843;Reuters消息:paul.sandle.thomsonreurs.com@reurs.net)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧